Ensifentrine for COPD: Identifying the Patients Who Benefit
- PMID: 39939049
- DOI: 10.1016/j.chest.2024.08.034
Ensifentrine for COPD: Identifying the Patients Who Benefit
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: R. S. served in an advisory board for Verona Pharmaceutical. None declared (S. R.).
Publication types
LinkOut - more resources
Full Text Sources